Navigating Rare Disease Advocacy: The CurePDE Journey

Feb 27, 2025·
Curtis Coughlin II
Curtis Coughlin II
· 1 min read
Abstract
Anna Sowa, Kristy McCay, and Curtis Coughlin discuss the insights on the challenges of diagnosis and treatment of pyridoxine-depedent epilepsy.
Date
Feb 27, 2025
Event
Moving Foward Medicine Series
Location

Recorded

Podcast Overview

In this episode of “Moving Medicine Forward” – The Podcast, Christine Eby, Director of Clinical Project Management & Therapeutic Strategy Lead at CTI, Anna Sowa, Chief Mission Officer at CurePDE, Curtis R. Coughlin II, PhD, MS, MBE, Associate Professor, Department of Pediatrics and Center for Bioethics and Humanities, and Kristy McCay, mom of a two-year-old living with pyridoxine-dependent epilepsy (PDE), join together to discuss the ongoing efforts to raise awareness and provide support for those affected by this rare condition. They share insights on the challenges of PDE diagnosis, the importance of newborn screening, and the role of gene editing in treatment. The conversation also explores CurePDE’s advocacy work, its partnerships